Prof Research published a new market report on home infusion therapy products. It presents the largest 10 manufacturers in the home infusion therapy products Market. The report is a professional and in-depth study on the current state of the global home infusion therapy products market. The report provides key statistics on the market of home infusion therapy products. This report covers 1 product: home infusion therapy products. It is a valuable source of guidance and direction for companies and individuals interested in the home infusion therapy products industry.

The global home infusion therapy products market was valued to be 11,755 million USD in 2021. The home infusion therapy products production value is anticipated to have grown with a CAGR of 4.69% in the coming years to reach 15,475 million USD in 2027.

Baxter is the world's largest manufacturer of home infusion therapy products, and it has a market share of 12.1% in value. Baxter International Inc. through its subsidiaries provides a portfolio of essential healthcare products. The Company’s segments include Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia-Pacific), and Hillrom.

Fresenius is the second largest manufacturer of home infusion therapy products in the world, and it has a market share of 10.4% in value. Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed.

B. Braun is the third largest manufacturer of home infusion therapy products in the world, and it has a market share of 8.8% in value. B. Braun is a German medical and pharmaceutical device company. The company’s operations are organized into three divisions – Hospital Care, Aesculap, and Avitum.

Terumo is the fourth largest manufacturer of home infusion therapy products in the world, and it has a market share of 7.8% in value. TERUMO CORPORATION is a manufacturer of medical supplies. The Company operates in three segments: the Cardiac and Vascular Company segment, the Hospital Company segment, and the Blood System Company segment.